
Healthcare enthusiast @FinnPartners with a love of storytelling. Avid #podcaster. Obsessed with all things #Theranos related and relatively new fan of #Formula1
Jerusalem, Israel
Joined September 2016
- Tweets1.3K
- Following550
- Followers266
- Likes5.2K
I’ve been following the #ElizabethHolmes case ever since I read @JohnCarreyrou’s second expose on the story back in 2015. I penned some reflections on how companies have risen to the challenge of transparent communication in the years since to keep patients safe via @FINNPartners
The trial and verdict of #ElizabethHolmes are more than just a cautionary tale. It highlights the responsibility of communicators. finnpartners.com/news-insigh… #theranos #corporatecommunications
Neurofeedback for #PTSD? It's not sci-fi. Data shows its clincial efficacy.
Check out @GraymattersH and the latest meta-analysis featuring Prism #neurofeedback!
❗ New clinical outcome data❗
Check out the latest meta-analysis with a robust review of the clinical effect of neurofeedback, and specifically, Prism neurofeedback, on PTSD.
Check out the data via @FrontiersIn : frontiersin.org/journals/psy…
Fantastic article by @realJacobBell via @BioPharmaDive
"For drug developers, the brain represents a final frontier of sorts, much like ocean’s depths or the reaches of space do for other scientists. Cracking it is “not for the faint of heart"..."
biopharmadive.com/news/psych…
Oh, the power of the #PBM! "...while shifting to adalimumab biosimilars would save up to $6B for the US health system, PBMs would lose up to 84% of profit — a major reason very few large payers have come on board." - more from @ZacharyBrennan via @endpts
endpts.com/over-a-year-after…
#PTSD does not only impact #vets. 13 million Americans live with PTSD, stemming from physical assault, abuse, combat, illness, accidents or a natural disaster. Today, @GraymattersH's novel Prism for PTSD is offering hope. Check out the peer-reviewed study! #selfneuromodulation
The results of this multicenter clinical trial demonstrated that Prism for PTSD offers patients living with #PTSD an effective and safe path toward improved mental health.
Our innovative technology provides clinics with a cost effective, self-neuromodulation treatment that augments standard therapy for PTSD patients.
Read more about the study's findings in today's announcement 👉 prnewswire.com/news-releases…
@nyulangone @sheba_medical @TAUMedFaculty @RambamHCC
#Heartfailure impacts 6.9M Americans. Check out @cvrx's latest feature in @fox9!
Loved bringing this story to life! Learn about #Barostim, the world's first #neuromodulation device for #heartfailure management.
fox9.com/news/medical-device…
It was an absolute pleasure working with Alice Park at @TIME on her latest piece featuring ALZpath Inc. and it's novel blood test for #Alzheimers.
Give it a read! #ClientNews
time.com/6565140/alzheimers-…
.... and a blood test for #Alzheimers is one step closer to becoming a reality! Check out @AlZpath's latest publication in @JAMANeuro, affirming the high diagnostic accuracy of its ALZpath’s pTau217 blood test in identifying #amyloid and #tau in the brain. DM for info! #client
jamanetwork.com/journals/jam…
Proud, and not in the least bit surprised 🏆 #FINNWin
#GlobalSABRE Winner: Healthcare Agency of the Year: @FINNPartners
"I’m seeing it in conversations here with people. I hear it from colleagues in Europe and Japan. What we do matters, it always did, but #mentalhealth in general and #PTSD in particular, has not always gotten adequate attention. Now it does." - Oded Kraft, @GraymattersH CEO and Co-Founder
In times of #trauma, it’s important to focus on resilience. Oded Kraft, GMH CEO and Co-Founder, and @Marc_Iskowitz of @MMMnews discuss the importance of mental health, and how the company has handled the increased need for trauma care.
Read more: mmm-online.com/home/channel/…
No suprises here! Congrats @GraymattersH on this achievement 🏆 For the millions of people living with #PTSD, the innovation of GMH's Prism for PTSD offers new hope. An empowering treatment with impactful results. #Client
GMH is taking home the 2023 USA #PrixGalien Best Startup award! 🏆🎉
It’s an honor to be recognized by @GalienFdn for our dedication to reimagining mental healthcare and improving patient lives. Stay tuned as we continue to push forward our critical mission - helping those living with #PTSD get better from the wounds of trauma.
Nechama (Feuerstein) Rosengarten retweeted
I'm proud to be in Israel to honor the courage, commitment, and bravery of the Israeli people.
Americans are grieving with you following last week’s terror attacks.
Is your company prepared for a crisis? "Know your vulnerabilities and develop a plan with potential risks identified and scenarios that could take place" - John Bianchi via #FINNHealthSummit
Have a #crisis? Not communicating is not an option. It results in media filling in the blank... even if you don't have information, keep the flow of information coming. - John Bianchi & Claire Anderson via #FINNHealthSummit
Been counting down the hours! Can't wait to hear from my amazing colleagues and reporter friendlies @stylesbymion and @gliadkovskaya about the state of media in today's climate #FINNHealthSummit
On October 17-18, FINN’s Global #Health Media Team will host the 2nd annual #media summit that brings together an incredible group of reporters with our global community - sharing insights, tips & professional development. A huge thank you to the panel members! #FINNHealthSummit
Just became a fan of @BestBuy and @GeekSquad... but for its healthy-focused pilot program! Love the innovation - and positive outcome - of bringing Geek Squad services to chronic care patients ❤️ More on this from @HeatherLandi via @FierceHealth
.@GeisingerHealth's pilot program with @BestBuy's @GeekSquad resulted in better adherence to care plans and more positive outcomes for chronic care patients, the health system reported, as it looks to expand its collaboration with the retailer
bit.ly/3sW81gp
Do you remember when you joined X? Today marks 7 years for me! Twitter/X has been a wild ride... and the platform has been my most utilized tool for staying on top of timely news stories and connecting with reporters 🎙️ #MyXAnniversary
Have you seen Andrea Park's latest piece via @FierceBiotech on @IbexMedAx? It's latest $55M VC round and Galen Breast HER2 product launch are just some of the exciting things happening at Ibex. Read here: fiercebiotech.com/medtech/ib…
And #breastcancer detection just got a whole lot smarter! Check out @IbexMedAx's Galen Breast HER2 AI-powered biomarker scoring solution, set to improve the outcome of cancer diagnosis and patient care. #client
Thrilled to launch Galen Breast HER2! Developed in collaboration with @AstraZeneca & Daiichi Sankyo, the new #AI solution supports accurate & rapid HER2 assessment that can help identify effective therapies for #breastcancer patients ibex-ai.com/ibex-launches-ga… #pathology #oncology
Creating an entirely new treatment modality with #PrismforPTDS, I am proud and humbled to work with #client @GraymattersH, bringing innovative solutions to mental disorder treatment.
As #PTSD affects ~9 million Americans, clinics are in search of innovative and scalable solutions to offer the many patients.
GrayMatters Health is at the forefront of these solutions, offering Prism for PTSD, a novel digital adjunct therapy.
Learn more: graymatters.health/













